Buy or sell Sana Biotechnology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Sana Biotechnology Stock

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.

About Sana Biotechnology Stock

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Management

Chief Business Officer

Christian Hordo

Chief Financial Officer

Nate Hardy

Chief Scientific Officer

Chad Cowan

President and Chief Executive Officer

Steve Harr

Chief Technology Officer

Andy May

General Counsel

James MacDonald

Chief Development Officer and Head of Portfolio Strategy

Sunil Agarwal

Chief People Officer

Robin Andrulevich

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Sana Biotechnology or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo